20 JANUARY – MONDAY – MAIN PROGRAMME (AULA BRASCA)

08:30 Registration
08:45 Opening Remarks and Welcome Address
09:00 LECTURE: “Horizon Europe Mission Board for Cancer: which opportunities” (Walter Ricciardi)
09:15 EXPERT PANEL DISCUSSION: Early-Stage HCC
MULTIDISCIPLINARY INTERACTIVE DECISION MAKING SESSION

  • Early-Stage Cases from MIOLive 2019: Were the experts right? What have we learned?
  • Presentation of new cases
10:45 Coffee Break
11:00 LIVE CASES
11:30 SESSION: IO & ADVANCED IMAGING
Moderators: Antonio Gasbarrini, Andrea Laghi, Piergiorgio Natali

  • Augmented Reality (Luigi Solbiati)
  • Robotics (Nahum Goldberg)
  • Fusion Imaging (Giampaolo Carrafiello, Anna Maria Ierardi)

Discussants: Maurizio Cariati, Alessandro Cina, Antonio Raffaele Cotroneo, Abdel-Naser Elzouki, Franca Meloni, Antonio Orlacchio, Najjar Taoufik
12:30 PRIMUM NON NOCERE: ablation (Laura Crocetti)
13:00 LUNCH & LEARN – MIOLIVE meets CIRSE
PROVING THE WORTH OF SOCIETY-SPONSORED CLINICAL RESEARCH
Moderators: Thomas Helmberger, Riccardo Manfredi

  • The importance of observational studies and the position of medical societies(Laura Crocetti)
  • CIRT study design (Thomas Helmberger)
  • CIREL study design (Roberto Iezzi)
  • CIEMAR study design (Franco Orsi)
14:00 HONORARY LECTURE: Intra-arterial gene therapy: where are we going? (Olivier Pellerin)
14:15 LIVE CASES
14:45 SESSION: INTERVENTIONAL MSK PROCEDURES: EXTRASPINAL LESIONS
Moderators: Francesco Arrigoni, Alexis Kelekis, Giulio Maccauro

  • Radiotherapy (Stefania Manfrida)
  • IO & curative (Rosario Francesco Grasso)
  • Consolidation (Dimitrious Filippiadis)
  • Embolization (Fernando Gomez Munoz)

Discussants: Alessandra Cassano, Roberto Cioni, Valentina Lancellotta,
Antonio Leone, Carmelo Pozzo, Michele Rossi, Antonio Ziranu
16:00 LIVE CASES
16:30 Coffee Break
16:45 EXPERT PANEL DISCUSSION: Intermediate-Stage HCC
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION

  • Intermediate-Stage Cases from MIOLive 2019: Were the experts right? What have we learned?
    Discussant: Tobias Jakobs
  • Presentation of new cases
18:30 Plenary Discussion on patients treated

 

21 JANUARY – TUESDAY – MAIN PROGRAMME (AULA BRASCA)

08:30 IO AND DIGITAL HEALTH TRANSFORMATION (DHT)
Moderators: Riccardo Manfredi, Vincenzo Valentini

  • DHT and Molecular tumor profiles: innovations and opportunities Giampaolo Tortora)
  • DHT and Data/Monitor BOT: innovations and opportunities (Carlotta Masciocchi)
  • DHT, AVATARS & Artificial Intelligence: innovations and opportunities (Nicola Dinapoli)
09:30 LECTURE:
09:00 LECTURE: THERANOSTICS IN INTERVENTIONAL ONCOLOGY: where are we going? (Alban Denys)
09:45 LIVE CASES
10:15 PRIMUM NON NOCERE: chemoembolization (Tiago Bilhim)
10:30 Coffee Break
10:45 LIVE CASES
11:15 EXPERT PANEL DISCUSSION: Advanced-Stage HCC
MULTIDISCIPLINARY INTERACTIVE DECISION MAKING SESSION

  • Advanced-Stage Cases from MIOLive 2019: Were the experts right? What have we learned?
  • Presentation of new cases
12:45 LIVE CASES
13:15 LUNCH & LEARN: INDUSTRY SYMPOSIUM
What is new in ablative (percutaneous/intra-arterial) procedures?
Moderators: AnnaMaria De Gaetano, Carmine Di Stasi
Sponsored by: Guerbet, Terumo, Boston, Hospital Service, Igea, RF Medical
14:15 LIVE CASES
14:45 PRIMUM NON NOCERE: radioembolization (Bora Peynircioglu)
15:00 5-YEAR RESULTS FROM MIOLIVE 2015: WERE THE EXPERTS RIGHT? WHAT’S CHANGED?
MULTIDISCIPLINARY INTERACTIVE DECISION MAKING SESSION
Moderator: Roberto Iezzi
Panelists: Antonio Basile, Mario Bezzi, Thomas Helmberger, Jaak Janssens,
George Kovacs, Josè Hugo Luz, Jens Ricke, Guido Torzilli, Thomas Vogl
16:00 LIVE CASES
16:20 BE INNOVATIVE, SHARE YOUR EXPERIENCE
REGISTERED LIVE CASES SHOWING NEW TECHNIQUES AND NEW DEVICES
Moderators: Maurizio Grosso, Andrea Veltri

  • SBRT & hepatic lesion (Francesco Cellini)
  • TIPS: tips & tricks (Massimiliano Allegritti, Giovanni Passalacqua)
  • FA & osteoid osteomas (Thomas Vogl)
  • Innovation & Presurgical Hepatic Procedures (Josè Hugo Luz)
  • Crioablation & renal lesion (Rosario Francesco Grasso)
17:30 LIVE CASES
18:00 Plenary Discussion on patients treated
18:15 End